Protein Signatures in Human MDA-MB-231 Breast Cancer Cells Indicating a More Invasive Phenotype Following Knockdown of Human Endometase/Matrilysin-2 by siRNA.

Protein Signatures in Human MDA-MB-231 Breast Cancer Cells Indicating a More Invasive Phenotype Following Knockdown of Human Endometase/Matrilysin-2 by siRNA.
复制标题

DOI:
10.7150/jca.2.165
复制
发表时间:
2011-03-16
期刊:
影响因子:
3.9
通讯作者:
Sang QX
Sang QX
中科院分区:
医学3区
文献类型:
--
作者:
Lee S;Terry D;Hurst DR;Welch DR;Sang QX

文献摘要

参考文献

被引文献

相似文献

人基质金属蛋白酶-26(MMP-26/子宫内膜酶/基质溶解素-2)是乳腺癌、前列腺癌和其他上皮来源的癌症的推定生物标志物。在人乳腺癌细胞系MDA-MB-231中使用小干扰RNA(siRNA)沉默MMP-26表达。免疫学和蛋白质组学方法,包括二维凝胶电泳和基质辅助激光解吸/电离飞行时间质谱,用于确定MMP-26敲低细胞中的差异蛋白质表达。对照和MMP-26敲低细胞的蛋白表达谱的比较揭示了9个差异调节的蛋白。其中5种蛋白质(热休克蛋白90、葡萄糖调节蛋白78(GRP 78)、膜联蛋白V、原肌球蛋白和过氧化物氧还蛋白II)上调,而α-微管蛋白、半胱氨酸蛋白酶抑制剂SA-III、乳腺癌转移抑制因子1(BRMS 1)和β-肌动蛋白下调。BRMS 1表达的这种减少伴随着通过基质包被的膜的侵袭的增加。这些结果表明MMP-26在浸润性和转移性乳腺癌中参与蛋白质调节的重要作用。
Human matrix metalloproteinase-26 (MMP-26/endometase/matrilysin-2) is a putative biomarker for carcinomas of breast, prostate, and other cancers of epithelial origin. MMP-26 expression was silenced using small interfering RNA (siRNA) in the human breast cancer cell line MDA-MB-231. Immunological and proteomics approaches, including two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization time-of-flight mass spectrometry, were employed to identify differential protein expression in MMP-26 knockdown cells. A comparison of the protein expression profiles of control and MMP-26 knockdown cells revealed nine differentially regulated proteins. Five of the proteins (heat shock protein 90, glucose-regulated protein 78 (GRP78), annexin V, tropomyosin, and peroxiredoxin II) were up-regulated, while alpha-tubulin, cystatin SA-III, breast cancer metastasis suppressor 1 (BRMS1) and beta-actin were down-regulated. This decrease of BRMS1 expression is concomitant with an increase of invasion through matrix-coated membranes. These results suggest an important role for MMP-26 in the regulation of proteins involved in invasive and metastatic breast cancers.
DOI: 10.1002/ijc.20294
发表时间: 2004-09-10
影响因子: 6.4
作者:
Lehtonen, ST;Svensk, AM;Kinnula, VL
通讯作者: Kinnula, VL
DOI: 10.1158/0008-5472.can-04-3019
发表时间: 2004-12-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Li, W;Savinov, AY;Strongin, AY
通讯作者: Strongin, AY
DOI: 10.1002/pmic.200401132
发表时间: 2005-03-01
期刊: PROTEOMICS
影响因子: 3.4
作者:
Hayashi, E;Kuramitsu, Y;Nakamura, K
通讯作者: Nakamura, K
DOI: 10.1111/j.0022-202x.2005.23640.x
发表时间: 2005-04-01
影响因子: 6.5
作者:
Ahokas, K;Skoog, T;Saarialho-Kere, U
通讯作者: Saarialho-Kere, U
DOI: 10.1042/bj20061390
发表时间: 2007-04-01
影响因子: 4.1
作者:
Lee, Seakwoo;Park, Hyun I.;Sang, Qing-Xiang Amy
通讯作者: Sang, Qing-Xiang Amy